Requirement for CD154 in the progression of atherosclerosis

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1313-1316

  Lutgens, Esther ^a   Gorelik, Leonid ^b   Daemen, Mat J A P ^a   De Muinck, Ebo D ^a   Grewal, Iqbal S ^b   Koteliansky, Victor E ^c   Flavell, Richard A ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE DISRUPTION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LIPID COMPOSITION; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ARTERIOSCLEROSIS; BASE SEQUENCE; CD40 LIGAND; CHOLESTEROL; DISEASE PROGRESSION; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES; TRIGLYCERIDES;

EID: 0032740818     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15271     Document Type: Article

References (20)

1. Ross, R. Atherosclerosis. An inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999).
2. Mach, F., Schönbeck, U. & Libby, P. CD40 signaling in vascular cells: A key role in atherosclerosis? Atherosclerosis 137, S89-S95 (1998).
3. Mach, F., Schönbeck, U., Sukhova, C.K., Atkinson, E. & Libby, P. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394, 200-203 (1998).
4. Grewal, I.S. & Flavell, R.A. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol. Today 17, 410-414 (1996).
5. Aruffo, A. et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72, 291-300 (1993).
6. Mach, F. et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40L signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94, 1931-1936 (1997).
7. Mach, F., Schönbeck, U., Bonnefoy, J.Y., Pober, J.S. & Libby, P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Induction of collagenase, stromelysin, and tissue factor. Circulation 96, 396-399 (1997).
8. Schönbeck, U. et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T-lymphocytes. A role for CD40 signaling in plaque rupture? Circ. Res. 81, 448-454 (1997).
9. Kornbluth, R., Kee, K. & Richman, D.D. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines. Proc. Natl. Acad. Sci. USA 95, 5205-5210 (1998).
10. Yellin, M.J. et al. Functional interactions of T cells with endothelial cells: The role of CD40L-CD40-mediated signals. J. Exp. Med. 182, 1857-1864 (1995).
11. Nakashima, Y, Plump, A.S., Raines, E.W., Breslow, J.L. & Ross, R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb, Vasc. Biol. 14, 133-140 (1994).
12. Stary, H.C. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 15, 1512-1531 (1995).
13. Lutgens, E. et al. Atherosclerosis in APOE*3 Leiden transgenic mice: from proliferative to atheromatous stage. Circulation 99, 276-283 (1999).
14. Johnson, R.C. et al. Absence of P-selectin delays fatty streak formation in mice. J. Clin. Invest. 99, 1037-1043 (1997).
15. Grewal, I.S., XU, J. & Flavell, R.A.: Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378, 617-620 (1995).
16. Gupta, S. et al. IFN-τ potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752-2761 (1997).
17. Dansky, H.M., Charlton, S.A., Harper, M. & Smith, J.D. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 94, 4642-4646 (1997).
18. Terkeltaub, R., Boisvert, W.A. & Curtiss, L.K. Chemokines and atherosclerosis. Curr. Opin. Lipidol. 9, 397-405 (1998).
19. Lutgens, E. et al. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc. Res. 41, 473-479 (1999).
20. Dijkstra, C.D., Dopp, E.A., Joling, P. & Kraal, G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54, 589-599 (1985).